Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FDA triple header. Food and Drug Administration.

GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies - 1 Nov 1995

Smart T

Abstract excerpt

The Antiviral Drugs Advisory Committee's favorable decisions on 3TC, saquinavir, and d4T in treating advanced HIV disease is discussed, as are study data and resistance issues related to each. While AIDS treatment activists supported the approval of all three drugs, they criticized details of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Didanosine
Share to Isoquinolines
Share to Salvage Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Saquinavir

Share to Stavudine

Share to United States Food and Drug Administration

Share to Zalcitabine

Share to Zidovudine

Source

Identifiers

PMID: 11362986

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-11362986-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FDA triple header. Food and Drug Administration.PMID 11362986Read ↗

IDSA update from the city of brotherly love.Semantic proximity Read ↗

Early nucleoside reverse transcriptase inhibitors for the treatment of HIV: A brief history of stavudine (D4T) and its comparison with other dideoxynucleosidesSemantic proximity Read ↗

New drugs-reports of new drugs recently approved by the FDA. Abacavir sulfate.Semantic proximity Read ↗

Anti-HIV agents. Monotherapy studies--points to consider.Semantic proximity Read ↗

The medical merry-go-round: drugs for 1998 are new but not novel.Semantic proximity Read ↗

Dolutegravir plus lamivudine for the treatment of HIV-1 infection.Semantic proximity Read ↗

New antiretroviral drugs part I: PIs.Semantic proximity Read ↗

Review of viral load and combination therapy data from 35th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy.Semantic proximity Read ↗

Antiretroviral therapy 2006: pharmacology, applications, and special situations.Semantic proximity Read ↗

3TC approved: now for the tough questions.Semantic proximity Read ↗

No compelling reason to adopt new antivirals whenever it is reasonable to wait.Semantic proximity Read ↗

A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.